Stockscreener 앱 받기
5.77
1.76%
0.10
시간 외 거래:
5.85
0.08
+1.39%
전일 마감가:
$5.67
열려 있는:
$5.77
하루 거래량:
23,117
Relative Volume:
0.18
시가총액:
$46.61M
수익:
$442.00K
순이익/손실:
$-30.46M
주가수익비율:
-9.459
EPS:
-0.61
순현금흐름:
$-27.47M
1주 성능:
-9.56%
1개월 성능:
+8.87%
6개월 성능:
-33.66%
1년 성능:
-28.61%
1일 변동 폭
$5.58
$5.9844
1주일 범위
$5.58
$6.50
52주 변동 폭
$3.8181
$12.00
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 개시 | H.C. Wainwright | Buy |
| 2022-05-02 | 개시 | Canaccord Genuity | Buy |
| 2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
Clene to Meet with FDA Leadership to Discuss CNM-Au8 Biomarker for ALS Treatment - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker With FDA Leadership - Yahoo Finance
Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership - The Globe and Mail
Clene Unveils Phase 3 Trial Design at NEALS - TipRanks
Clene Showcases Progress on CNM-Au8 for Neurodegenerative Diseases at Investor Conferences - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences - Yahoo Finance
Clene Inc (CLNN-Q) QuotePress Release - The Globe and Mail
(CLNN) Trading Report - Stock Traders Daily
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements - Yahoo Finance
Clene Secures $7.3M in Funding to Advance Neurodegenerative Disease Treatment - Vancity Buzz
Canaccord retains price target, buy rating on Clene shares post-webinar - Investing.com Canada
IBN Coverage: Clene (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences - Yahoo Finance
Clene Inc. to Present at Two Upcoming Investor Conferences in October - Vancity Buzz
Clene to Present at Upcoming October Conferences - The Manila Times
Clene (NASDAQ:CLNN) Price Target Cut to $86.00 by Analysts at Canaccord Genuity Group - Defense World
Independent Chairman of the Board of Clene Picks Up 26% More Stock - Simply Wall St
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares - Yahoo Finance
Canaccord cuts Clene stock price target, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Clene stock price target, maintains Buy rating - Investing.com
Clene Secures $7.3 Million in Funding Through Direct Offering and Private Placements - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M - Yahoo Finance
Clene Inc. director David Matlin buys $438k in company stock - Investing.com
Clene Inc. CEO purchases $47,500 in company stock - Investing.com India
Clene Inc. chief science officer purchases $97,432 in company stock By Investing.com - Investing.com Australia
Clene Inc. chief science officer purchases $97,432 in company stock - Investing.com India
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements - Yahoo Finance
Clene (CLNN) Gains Momentum In The Extended Session After Completing Investment Offering - Stocks Telegraph
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility - The Manila Times
Clene Inc. CEO purchases $47,500 in company stock By Investing.com - Investing.com Australia
Insider Buying: Chief Science Officer Mark Mortenson Acquires Sh - GuruFocus.com
Clene Inc. Secures $7.3 Million in Funding Through Direct Offerings and Private Placements - Vancity Buzz
Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements - The Globe and Mail
Clene Inc. secures $7.3 million in stock and warrant sales By Investing.com - Investing.com Australia
Clene Inc. modifies loan terms and adjusts warrant exercise price - Investing.com India
Clene Inc. modifies loan terms and adjusts warrant exercise price By Investing.com - Investing.com Canada
Clene Inc. secures $7.3 million in stock and warrant sales - Investing.com India
Clene launches $7.3M registered direct offering - Seeking Alpha
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules - The Manila Times
Clene Inc. announced that it expects to receive $3.810506 million in funding - Marketscreener.com
Clene (NASDAQ:CLNN) Stock Quotes, Forecast and News Summary - Benzinga
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership - Yahoo Finance
Clene to Meet with FDA Leadership to Discuss CNM-Au8 Data for ALS Treatment - Vancity Buzz
The Globe and Mail - The Globe and Mail
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clene Inc 주식 (CLNN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
| Etherington Robert Dee | Chief Executive Officer |
Sep 30 '24 |
Buy |
4.75 |
10,000 |
47,500 |
40,149 |
| Etherington Robert Dee | Chief Executive Officer |
Jul 29 '24 |
Option Exercise |
3.00 |
27,320 |
81,960 |
30,149 |
| General Resonance LLC | 10% Owner |
Apr 30 '24 |
Sale |
0.42 |
13,000 |
5,416 |
15,326,712 |
| General Resonance LLC | 10% Owner |
May 01 '24 |
Sale |
0.40 |
13,000 |
5,148 |
15,313,712 |
| General Resonance LLC | 10% Owner |
Apr 24 '24 |
Sale |
0.33 |
10,000 |
3,278 |
15,349,712 |
| General Resonance LLC | 10% Owner |
Apr 09 '24 |
Sale |
0.39 |
22,500 |
8,674 |
15,428,212 |
| MATLIN DAVID J | Director |
Nov 10 '23 |
Buy |
0.41 |
250,002 |
102,501 |
7,043,686 |
2.21%
자본화:
|
볼륨(24시간):